Carl Anderson
Advertisement
Articles by Carl Anderson
Shedding light on common EMR concerns about privacy, government regulations, and data integrity.
Carl Anderson, senior consultant for Biologics Consulting Group, addresses the frequent overuse of Notes to File and concludes that documenting a mistake means absolutely nothing during an FDA inspection.
Advertisement
Latest Updated Articles
Key Updates to the 1572Published: May 23rd 2012 | Updated:
Note to File (NTF) is Not an FDA PanaceaPublished: March 1st 2008 | Updated:
The Ins and Outs of Electronic Medical RecordsPublished: September 1st 2008 | Updated:
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
How AI, Automation, and FSP Partners Are Reshaping Global Pharmacovigilance
2
Investigative Site Investment, Preparedness, and Experience with Digital Solutions
3
ACT Brief: AI-Driven Pharmacovigilance, Site-Led Digital Investments, and Smarter Multi-Touch Recruitment
4
FDA Clears Itvisma as First Gene Therapy for Adolescents and Adults With SMA
5
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
